This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Vakzine Projekt Management Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Albrecht Läufer: Innovator in Biotechnological Solutions
Introduction
Albrecht Läufer is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions that combine biological agents with bacterial cells.
Latest Patents
Läufer holds a patent for a groundbreaking invention titled "Combination of a bacterial cell and a biologically active agent." This invention relates to a combination comprising a bacterial cell that includes at least one recombinant nucleic acid molecule encoding a phagolysosomal escape peptide or polypeptide. The second constituent of this combination is a biologically active agent. In certain embodiments, this combination is designed for use as a vaccine to induce an immune response in mammals.
Career Highlights
Albrecht Läufer is associated with Vakzine Projekt Management GmbH, where he applies his expertise in biotechnology to advance vaccine development. His work focuses on creating innovative solutions that enhance immune responses, contributing to the field of immunology.
Collaborations
Läufer collaborates with esteemed colleagues such as Bernd Eisele and Leander Grode, who share his commitment to advancing biotechnological research and development.
Conclusion
Albrecht Läufer's contributions to biotechnology, particularly through his patented inventions, highlight his role as an innovator in the field. His work continues to pave the way for advancements in vaccine development and immune response enhancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile